Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Aug 31, 2011

Premium

LabCorp has launched HCV GenoSure NS3/4A, a Sanger sequencing-based assay that reports mutations to NS3 and NS4A that are associated with resistance to boceprevir, telaprevir, and HCV protease inhibitors.

The assay was developed at Monogram Biosciences, and will be the first in a series of HCV drug resistance assays, according to the company. The test is available for clinical and commercial use.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.